GENE ONLINE|News &
Opinion
Blog

Deals
Licensing Parkinson’s Disease
Alectos Promised $722 Million in Parkinson’s Collab With Biogen
2022-06-07
M&A Bristol Myers Squibb
BMS Buys Turning Point Therapeutics For $4.1 Billion, Bringing In Lung Cancer Drug
2022-06-06
Funding Protein Degraders
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
Licensing Astellas Pharma
Astellas’ $20.5M Deal With GO Therapeutics to Develop Immuno-Oncology Therapeutics
2022-06-02
Funding Genome
Ultima Genomics Promises $100 Genome After Raising $600 Million
2022-06-01
Funding Neurodegenerative Disease
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Licensing Neurological Disorder
Denali Taps PharmEnable to Discover AI-Based Small Molecule Candidates for Neurological Diseases
2022-05-30
Funding Protein
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Deals Cancer Immunotherapy
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Licensing CDMO
Lonza Signs CDMO Deal to Break Into Israeli Market
2022-05-25
Deals Bayer
Bayer Terminates CAR T-Cell Deal With Atara After Patient Death
2022-05-20
Funding Oncology
China’s Hengrui Buds Off New Biotech With 11 Therapeutic Programs
2022-05-19
Licensing Merck
Kelun Pharmaceuticals to Receive Up To $1.4 Billion From Merck in Lowkey Deal
2022-05-19
Funding Gene Therapy
Kriya Bags $270 Million Series C to Support Integrated Gene Therapies
2022-05-18
R&D Evotec SE
Evotec Leverages Sernova’s Cell Pouch to Develop Diabetes Stem Cell Treatment
2022-05-18
1 … 18 19 20 21 22 … 47
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top